Meeting
2022 ASCO Annual Meeting
Population-based retrospective analysis of response assessment criteria in patients with glioblastoma.
Authors
Parandoush Abbasian
Medical Physics, Physics and Astronomy, University of Manitoba, Winnipeg, MB, Canada
Parandoush Abbasian , Lawrence Ryner , Pascal Lambert , Anmol Mann , Jai Shankar , Marco Essig , Marshall W. Pitz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Primary CNS Tumors–Glioma
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 2041)
DOI
10.1200/JCO.2022.40.16_suppl.2041
Abstract #
2041
Poster Bd #
379
Abstract Disclosures
Similar Posters
First Author: Yasaman Damestani
Poster
2023 ASCO Annual Meeting
Short-length DNA fragments in plasma to predict clinical outcome in unresected glioblastoma patients.
First Author: Maxime Fontanilles
Poster
2022 ASCO Annual Meeting
Bortezomib sensitization of recurrent glioblastoma with unmethylated MGMT promoter to temozolomide, a phase II study (NCT03643549).
First Author: Dorota Goplen
Poster
2022 ASCO Annual Meeting
A single-institution, retrospective examination of new contrast enhancement, progression, and pseudoprogression in IDH mutant glioma.
First Author: Ethan Wetzel